186 related articles for article (PubMed ID: 38359564)
21. Using ePROMs for follow-up after palliative radiotherapy: An exploratory study with patients and health care providers.
Oldenburger E; Neyens I; Coolbrandt A; Isebaert S; Sevenants A; Van Audenhove C; Haustermans K
Patient Educ Couns; 2022 Jul; 105(7):2355-2361. PubMed ID: 34949467
[TBL] [Abstract][Full Text] [Related]
22. A mixed-methods study of cyclin-dependent kinase 4 and 6 inhibitor symptom burden and quality of life among metastatic breast cancer patients and providers.
Oswald LB; Arredondo B; Kadono M; Martinez-Tyson D; Meade CD; Penedo F; Antoni MH; Soliman H; Costa RLB; Jim HSL
Cancer Med; 2021 Jul; 10(14):4823-4831. PubMed ID: 34165265
[TBL] [Abstract][Full Text] [Related]
23. Palliative care experiences of adult cancer patients from ethnocultural groups: a qualitative systematic review protocol.
Busolo D; Woodgate R
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):99-111. PubMed ID: 26447011
[TBL] [Abstract][Full Text] [Related]
24. Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications.
Stefanovic S; Wallwiener M; Karic U; Domschke C; Katic L; Taran FA; Pesic A; Hartkopf A; Hadji P; Teufel M; Schuetz F; Sohn C; Fasching P; Schneeweiss A; Brucker S
Support Care Cancer; 2017 Feb; 25(2):549-558. PubMed ID: 27747478
[TBL] [Abstract][Full Text] [Related]
25. Effectiveness and implementation of SHared decision-making supported by OUTcome information among patients with breast cancer, stroke and advanced kidney disease: SHOUT study protocol of multiple interrupted time series.
Hackert MQN; Ankersmid JW; Engels N; Prick JCM; Teerenstra S; Siesling S; Drossaert CHC; Strobbe LJA; van Riet YEA; van den Dorpel RMA; Bos WJW; van der Nat PB; van den Berg-Vos RM; van Schaik SM; Garvelink MM; van der Wees PJ; van Uden-Kraan CF;
BMJ Open; 2022 Aug; 12(8):e055324. PubMed ID: 35914919
[TBL] [Abstract][Full Text] [Related]
26. Promoting and supporting self-management for adults living in the community with physical chronic illness: A systematic review of the effectiveness and meaningfulness of the patient-practitioner encounter.
Rees S; Williams A
JBI Libr Syst Rev; 2009; 7(13):492-582. PubMed ID: 27819974
[TBL] [Abstract][Full Text] [Related]
27. A text message intervention to support women's physical and mental health after breast cancer treatments (EMPOWER-SMS): a randomised controlled trial protocol.
Singleton A; Partridge SR; Raeside R; Regimbal M; Hyun KK; Chow CK; Sherman K; Elder E; Redfern J
BMC Cancer; 2019 Jul; 19(1):660. PubMed ID: 31272399
[TBL] [Abstract][Full Text] [Related]
28. Gaps in Care and Support for Patients With Advanced Breast Cancer: A Report From the Advanced Breast Cancer Global Alliance.
Fallowfield L; Boyle FM; Travado L; Kiely BE; Jewell P; Aubel D; Cardoso F
JCO Glob Oncol; 2021 Jun; 7():976-984. PubMed ID: 34156869
[TBL] [Abstract][Full Text] [Related]
29. Facilitators and barriers to implementing electronic patient-reported outcome and experience measures in a health care setting: a systematic review.
Glenwright BG; Simmich J; Cottrell M; O'Leary SP; Sullivan C; Pole JD; Russell T
J Patient Rep Outcomes; 2023 Feb; 7(1):13. PubMed ID: 36786914
[TBL] [Abstract][Full Text] [Related]
30. Living with metastatic breast cancer (LIMBER): experiences, quality of life, gaps in information, care and support of patients in the UK.
Fallowfield L; Starkings R; Palmieri C; Tait A; Stephen L; May S; Habibi R; Russ S; Shilling V; Jenkins V
Support Care Cancer; 2023 Jul; 31(8):459. PubMed ID: 37432501
[TBL] [Abstract][Full Text] [Related]
31. Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
Twelves C; Cortés J; O'Shaughnessy J; Awada A; Perez EA; Im SA; Gómez-Pardo P; Schwartzberg LS; Diéras V; Yardley DA; Potter DA; Mailliez A; Moreno-Aspitia A; Ahn JS; Zhao C; Hoch U; Tagliaferri M; Hannah AL; Rugo HS
Eur J Cancer; 2017 May; 76():205-215. PubMed ID: 28360015
[TBL] [Abstract][Full Text] [Related]
32. Quality of life and care needs in women with estrogen positive metastatic breast cancer: a qualitative study.
Lee Mortensen G; Madsen IB; Krogsgaard R; Ejlertsen B
Acta Oncol; 2018 Jan; 57(1):146-151. PubMed ID: 29202668
[TBL] [Abstract][Full Text] [Related]
33. Patient-Reported Outcomes for Breast Cancer.
Tevis SE; James TA; Kuerer HM; Pusic AL; Yao KA; Merlino J; Dietz J
Ann Surg Oncol; 2018 Oct; 25(10):2839-2845. PubMed ID: 29971671
[TBL] [Abstract][Full Text] [Related]
34. Electronic patient-reported outcome measures using mobile health technology in rheumatology: A scoping review.
Shelton J; Casey S; Puhl N; Buckingham J; Yacyshyn E
PLoS One; 2021; 16(7):e0253615. PubMed ID: 34292955
[TBL] [Abstract][Full Text] [Related]
35. International development of a patient-centered core outcome set for assessing health-related quality of life in metastatic breast cancer patients.
de Ligt KM; de Rooij BH; Hedayati E; Karsten MM; Smaardijk VR; Velting M; Saunders C; Travado L; Cardoso F; Lopez E; Carney N; Wengström Y; Ives A; Velikova G; Sousa Fialho MDL; Seidler Y; Stamm TA; Koppert LB; van de Poll-Franse LV;
Breast Cancer Res Treat; 2023 Apr; 198(2):265-281. PubMed ID: 36662394
[TBL] [Abstract][Full Text] [Related]
36. Making the unbearable, bearable: Qualitative examination of patient, family and nurses' perspectives on the role and value of specialist metastatic breast care nurses.
Franklin M; Lewis S; Townsend J; Warren M; Boyle F; Smith AL
Eur J Oncol Nurs; 2024 Apr; 69():102523. PubMed ID: 38342058
[TBL] [Abstract][Full Text] [Related]
37. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007.
Montazeri A
J Exp Clin Cancer Res; 2008 Aug; 27(1):32. PubMed ID: 18759983
[TBL] [Abstract][Full Text] [Related]
38. Quality of working life can protect against cognitive and emotional vulnerability in women living with metastatic breast cancer: a cross-sectional study.
Chapman B; Grunfeld EA; Derakshan N
J Cancer Surviv; 2023 Oct; 17(5):1295-1308. PubMed ID: 35038120
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
